Lewy body dementia — clinical, pathological and neurochemical interconnections
Senile dementia of Lewy body type or Lewy body dementia (SDLT or LBD) is defined as a Lewy body associated disease presenting in the elderly primarily with dementia with variable extrapyramidal disorder. Characteristic clinical symptoms include fluctuating cognitive impairment, psychotic features such as hallucinations and a particular sensitivity to neuroleptic medication. Although apolipoprotein e4 allele is increased 2–3 fold in SDLT (as in Alzheimer’s disease) and β-amyloidosis occurs in most cases, the most robust neurobiological correlate of the dementia so far identified appears to be extensive cholinergic deficits in the neocortex. This is consistent with previously reported correlations between cortical cholinergic activity and dementia in Parkinson’s disease (PD) and Alzheimer’s disease. There is also a significant interaction between the density of limbic cortical Lewy bodies and dementia in both SDLT and PD, although the cortical neuronal population affected remains to be identified. Cortical Lewy body density is positively correlated with the age of disease onset in PD and SDLT. This may account for the increased incidence of psychiatric syndromes, as opposed to extrapyramidal disorder in Lewy body disease with advancing age as may age-related loss of cholinergic activity in cortical areas such as the hippocampus.
KeywordsLewy Body Senile Dementia Lewy Body Dementia Neurochemical Pathology Neuroleptic Medication
Unable to display preview. Download preview PDF.
- Byrne EJ (1995) Cortical Lewy body disease: an alternative view. In: Levy R, Howard R (eds) Developments in dementia and functional disorders in the elderly. Wrightson, London, pp 21–30.Google Scholar
- Byrne EJ, Lennox G, Lowe J, Godwin-Austen RB, Jefferson D, Lowe J, Mayer RJ, Landon M, Doherty FJ (1991) Diagnostic criteria for dementia associated with cortical Lewy bodies. Dementia 2: 283–284.Google Scholar
- Perry EK, Perry RH (1995) Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn.Google Scholar
- Perry EK, Irving D, Kerwin JM, McKeith IG, Thompson P, Collerton D, Fairbairn AF, Ince PG, Morris CM, Cheng AV, Perry RH (1993) Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson’s and distinction from Alzheimer’s disease. Alz Dis Assoc Disord 7(2): 69–79.CrossRefGoogle Scholar
- Sahgal A, Galloway PG, McKeith IG, Edwardson JA, Lloyd S (1992a) A comparative study of attentional deficits in senile dementia of Alzheimer and Lewy body types. Dementia 3: 350–354.Google Scholar
- Sawle GV (1995) Living neurochemistry: the dopamine system. The Neurosciences 7: 173–177.Google Scholar